STRATA Skin Sciences Shares Fall 21% Amid Johns Hopkins Dermatology Program Expansion
ByAinvest
Wednesday, Feb 18, 2026 11:08 am ET1min read
SSKN--
STRATA Skin Sciences shares fell 21% despite the company announcing that Johns Hopkins Dermatology added the XTRAC 308 nm excimer laser to its clinical offerings. The addition strengthens Johns Hopkins' capabilities in treating chronic inflammatory and autoimmune skin conditions. STRATA CEO Dr. Dolev Rafaeli highlighted the critical role of academic medical centers in advancing precision treatment strategies.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet